HAVCR2 and acute myeloid leukemia: Additionally, previous studies in murine models of AML highlighted the association between upregulation of the PD-1/PD-L1 axis and high frequency of CD8+ T cells co-expressing PD-1 and TIM-3 with impaired anti-leukemic responses and disease progression [121,122].